Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The second bromodomain (BD2) found in BET family proteins (BRD2, BRD3, BRD4, and BRDT). BD2 is an epigenetic reader that recognizes acetylated lysine residues on histone tails, thereby regulating gene expression. Inhibition of BD2 is being explored as a therapeutic strategy in cancer and inflammatory diseases.
Inhibition of acetylated lysine binding
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bromodomain-containing protein Second Bromodomain (BD2).